Rebuttal Letters Issued to Shareholders of NYMOX PHARMACEUTICAL CORP

lunedì, 10 Luglio 2023
1 minuto di lettura

(Adnkronos) – CARSON CITY, Nevada and LONDON, July 10, 2023 /PRNewswire/ — 

WHO:  Newly formed organization, The Committee to Restore Nymox Shareholder Value, Calls for Shareholder Support 

WHAT:  Following the distribution of a press release by Nymox Pharmaceutical Corporation (the Company) regarding a NASDAQ Hearing Delist Decision at the open of business on July 7, 2023, rebuttal letters are being issued to all Company shareholders. Access the documents at www.crnsv.com
 

When:  July 10, 2023 

Where:  CARSON CITY, Nevada; LONDON 

Why:  Summary of Rebuttal Letters:  

View original content:https://www.prnewswire.co.uk/news-releases/rebuttal-letters-issued-to-shareholders-of-nymox-pharmaceutical-corp-301873345.html
 

 

Lascia un commento

Your email address will not be published.

Questo sito utilizza Akismet per ridurre lo spam. Scopri come vengono elaborati i dati derivati dai commenti.